Advancing mRNA-based Therapeutics for In Vivo Cellular Reprogramming: An Academic Perspective
Time: 11:30 am
day: Day Two
Details:
- Utilizing highly efficient CD4+ T-cell targeting and genetic recombination using engineered CD4+ cell homing mRNA LNPs
- Demonstrating efficacy in reducing fibrosis and restoring cardiac function in mice
- Discussing applications to produce CAR-T cells in vivo using modified mRNA to treat various diseases
